| Vahid Bordbar, | |
|
2325 Palos Verdes Dr W Ste 220, Palos Verdes Estates, CA 90274-2777 | |
| (424) 327-2990 | |
| (424) 327-2996 |
| Full Name | Vahid Bordbar |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 2325 Palos Verdes Dr W Ste 220, Palos Verdes Estates, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861845273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | 45086 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vahid Bordbar, 2325 Palos Verdes Dr W Ste 220, Palos Verdes Estates, CA 90274-2777 Ph: (424) 327-2990 | Vahid Bordbar, 2325 Palos Verdes Dr W Ste 220, Palos Verdes Estates, CA 90274-2777 Ph: (424) 327-2990 |
News Archive
Well over 100,000 Veterans exposed to herbicides while serving in Vietnam and other areas will have an easier path to qualify for disability pay under a proposed regulation published by the Department of Veterans Affairs (VA) that adds three new illnesses to the list of health problems found to be related to Agent Orange and other herbicide exposures.
Research shows that using a glucagon-like peptide-1 receptor agonist instead of a rapid-acting insulin analogue at mealtimes can reduce glycaemic variability in high-risk patients with Type 2 diabetes.
Middle school students who perform more vigorous physical activity than their more sedentary counterparts tend to do better in school, according to a study published today.
Aesyntix Physician Network (APN), a group purchasing organization (GPO) for dermatology and cosmetic surgery practices, and the American Society for Dermatologic Surgery (ASDS) today announced they have formed a partnership to provide ASDS members with significant savings opportunities on commonly purchased medical/surgical supplies and other products and services, including Revenue Cycle Management solutions.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 6 days ago
Gavin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829 | |
Jennifer Kawamura, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829 | |
Mrs. Shelly Mcfadden Kumar, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Via Rivera, Palos Verdes Estates, CA 90274 Phone: 310-544-0337 | |
Attah Nazerzadeh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 Pheasant Ln, Palos Verdes Estates, CA 90274 Phone: 310-308-0944 | |
Mrs. Brittney Wong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829 |